Home
/
Ernexa Therapeutics Inc.
/
Financials
/
Quarterly
Ernexa Therapeutics Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Ernexa Therapeutics Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2024
$487.0K
Nov 7, 2025
Q2
2025
Jun 30, 2024
$47.0K
Aug 13, 2025
Q1
2025
Mar 31, 2024
$47.0K
May 7, 2025
Q3
2024
Sep 30, 2023
$51.0K
Nov 12, 2024
Q1
2024
Mar 31, 2023
$0
May 14, 2024
Q3
2023
Sep 30, 2022
$0
Nov 13, 2023
Q1
2019
Mar 31, 2019
$4.83M
May 14, 2019
Q1
2019
Mar 31, 2018
$5.76M
May 14, 2019
Q3
2017
Sep 30, 2017
$5.20M
Nov 8, 2017
Q2
2017
Jun 30, 2017
$5.55M
Aug 4, 2017
Q1
2018
Mar 31, 2017
$5.23M
May 11, 2018
Q3
2017
Sep 30, 2016
$5.44M
Nov 8, 2017
Q2
2017
Jun 30, 2016
$5.41M
Aug 4, 2017
Q1
2017
Mar 31, 2016
$5.48M
May 4, 2017
Q3
2016
Sep 30, 2015
$6.08M
Nov 9, 2016
Q2
2016
Jun 30, 2015
$6.19M
Aug 4, 2016
Q1
2016
Mar 31, 2015
$5.73M
May 9, 2016
Q3
2015
Sep 30, 2014
$6.01M
Nov 9, 2015
Q2
2015
Jun 30, 2014
$6.87M
Aug 10, 2015
Q1
2015
Mar 31, 2014
$6.42M
May 8, 2015
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Sep 30, 2020
$1.48M
Nov 13, 2020
Q2
2020
Jun 30, 2020
$754.0K
Aug 7, 2020
Q1
2020
Mar 31, 2020
$2.39M
May 20, 2020
Q3
2020
Sep 30, 2019
$4.58M
Nov 13, 2020
Q2
2020
Jun 30, 2019
$5.23M
Aug 7, 2020
Q1
2020
Mar 31, 2019
$4.83M
May 20, 2020
Q3
2019
Sep 30, 2018
$6.00M
Nov 1, 2019
Q2
2019
Jun 30, 2018
$5.65M
Aug 12, 2019
Q1
2019
Mar 31, 2018
$5.76M
May 14, 2019
Q3
2018
Sep 30, 2017
$5.20M
Nov 9, 2018
Q2
2018
Jun 30, 2017
$5.55M
Aug 6, 2018
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2014
Sep 30, 2014
$6.01M
Nov 7, 2014
Q2
2014
Jun 30, 2014
$6.87M
Aug 14, 2014
Q1
2014
Mar 31, 2014
$6.42M
May 15, 2014
Q3
2014
Sep 30, 2013
$5.53M
Nov 7, 2014
Q2
2014
Jun 30, 2013
$5.53M
Aug 14, 2014
Q1
2014
Mar 31, 2013
$6.12M
May 15, 2014
Q3
2013
Sep 30, 2012
$6.05M
Nov 14, 2013
Q2
2013
Jun 30, 2012
$6.02M
Aug 14, 2013
Q1
2013
Mar 31, 2012
$6.07M
May 13, 2013
Q3
2012
Sep 30, 2011
$5.87M
Nov 9, 2012
Q2
2012
Jun 30, 2011
$5.89M
Aug 14, 2012
Q1
2012
Mar 31, 2011
$6.00M
May 11, 2012
Q3
2011
Sep 30, 2010
$6.51M
Nov 14, 2011
Q2
2011
Jun 30, 2010
$6.19M
Aug 12, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.24M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($3.14M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($8.20M)
May 7, 2025
Q3
2025
Sep 30, 2024
($26.60M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($5.53M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($6.65M)
May 7, 2025
Q3
2024
Sep 30, 2023
($5.59M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($4.51M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($5.42M)
May 14, 2024
Q3
2023
Sep 30, 2022
($7.32M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($3.40M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($9.38M)
May 11, 2023
Q3
2022
Sep 30, 2021
($85.99M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($10.09M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($18.52M)
Jul 1, 2022
Q3
2021
Sep 30, 2020
($2.02M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($2.03M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($1.02M)
May 17, 2021
Q3
2020
Sep 30, 2019
($351.0K)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($90.0K)
Aug 7, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.99M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($2.50M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($2.73M)
May 7, 2025
Q3
2025
Sep 30, 2024
($2.26M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($4.93M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($5.79M)
May 7, 2025
Q3
2024
Sep 30, 2023
($5.51M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($4.55M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($5.32M)
May 14, 2024
Q3
2023
Sep 30, 2022
($8.30M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($13.88M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($6.30M)
May 11, 2023
Q3
2022
Sep 30, 2021
($86.28M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($10.01M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($8.92M)
Jul 1, 2022
Q3
2021
Sep 30, 2020
($2.01M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($2.02M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($1.01M)
May 17, 2021
Q3
2020
Sep 30, 2019
($316.0K)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($2.0K)
Aug 7, 2020